RAGE and HMGB1 Expression in Orbital Tissue Microenvironment in Graves’ Ophthalmopathy

RAGE and HMGB1 Expression in Orbital Tissue Microenvironment in Graves’ Ophthalmopathy

Graves’ ophthalmopathy (GO) is a chronic autoimmune inflammatory disorder involving orbital tissues. A receptor for advanced glycation end products (RAGE) and its ligand high mobility group box 1 (HMGB1) protein trigger inflammation and cell proliferation and are involved in the pathogenesis of vari...

Полное описание

Библиографические подробности
Главные авторы:	Dominika Łacheta, Krzysztof B. Poślednik, Katarzyna Czerwaty, Nils Ludwig, Marta Molińska-Glura, Ireneusz Kantor, Anna Jabłońska-Pawlak, Piotr Miśkiewicz, Alicja Głuszko, Zygmunt Stopa, Jacek Brzost, Mirosław J. Szczepański
Формат:	Статья
Язык:	English
Опубликовано:	Hindawi Limited 2021-01-01
Серии:	Mediators of Inflammation
Online-ссылка:	http://dx.doi.org/10.1155/2021/8891324

Схожие документы

HMGB1 Carried by Small Extracellular Vesicles Potentially Plays a Role in Promoting Acquired Middle Ear Cholesteatoma
по: Michał W. Łuczak, и др.
Опубликовано: (2023-11-01)

Graves' ophthalmopathy
по: Swiss Medical Weekly
Опубликовано: (2002-01-01)

Autophagy in graves’ ophthalmopathy
по: Yu-Qing Chen, и др.
Опубликовано: (2023-04-01)

Treatment of Graves' ophthalmopathy
Опубликовано: (2010-09-01)

Psychological aspects of Graves’ ophthalmopathy
по: Waleed K W Al-Badri, и др.
Опубликовано: (2024-08-01)

Graves' ophthalmopathy: interdisciplinary approach
Опубликовано: (2010-12-01)

The Influence of Juvenile Graves’ Ophthalmopathy on Graves’ Disease Course
по: Jurate Jankauskiene, и др.
Опубликовано: (2017-01-01)

Perspectives in Therapy of Chronic Rhinosinusitis
по: Jacek Brzost, и др.
Опубликовано: (2022-09-01)

Immunological Aspects of Chronic Rhinosinusitis
по: Katarzyna Czerwaty, и др.
Опубликовано: (2022-09-01)

Endoscopic Orbital Decompression for Graves’ Ophthalmopathy
по: Tang, Ing Ping, и др.
Опубликовано: (2008)

Update on pathogenesis and immunology of Graves’ ophthalmopathy
по: Larysa Krajewska-Węglewicz, и др.
Опубликовано: (2018-12-01)

Treatment of ophthalmopathy in the course of Graves’ disease
по: Magdalena Woźniak, и др.
Опубликовано: (2019-09-01)

Graves’ Ophthalmopathy Misdiagnosed as Relapsing Conjunctivitis
по: Irini P. Chatziralli, и др.
Опубликовано: (2010-09-01)

Graves’ ophthalmopathy – thyroid eye disease
по: Dagna Siedlecka, и др.
Опубликовано: (2019-08-01)

Treatment of ophthalmopathy in the course of Graves’ disease
по: Magdalena Woźniak, и др.
Опубликовано: (2019-09-01)

Age Influences the Severity of Graves' Ophthalmopathy
по: Muh-Chiou Lin, и др.
Опубликовано: (2008-06-01)

Practical Guidelines Management of Graves Ophthalmopathy
по: Imam Subekti, и др.
Опубликовано: (2019-10-01)

Precision Medicine in Graves’ Disease and Ophthalmopathy
по: Giusy Elia, и др.
Опубликовано: (2021-10-01)

Validation of Indonesian Graves’ Ophthalmopathy Quality of Life Questionnaire and Its Association with Clinical Activity and Severity of Graves’ Ophthalmopathy
по: Cecilia Anggraini, и др.
Опубликовано: (2024-10-01)

The Influence of Prior Hyperthyroidism on Euthyroid Graves’ Ophthalmopathy
по: Karolien Termote, и др.
Опубликовано: (2014-01-01)

Steroid Treatment Focused Management of Graves’ Ophthalmopathy
по: Condeng Y. H., и др.
Опубликовано: (2024-09-01)

Tear-derived exosomal biomarkers of Graves’ ophthalmopathy
по: Ting-Ting Shi, и др.
Опубликовано: (2022-12-01)

Current insights of applying MRI in Graves’ ophthalmopathy
по: Cheng Song, и др.
Опубликовано: (2022-09-01)

Comparative evaluation of oculometric variables in graves' ophthalmopathy
по: Hélio Amante Miot, и др.
Опубликовано: (2009-01-01)

The association of carotid cavernous fistula with Graves′ ophthalmopathy
по: Ozlem Celik, и др.
Опубликовано: (2013-01-01)

Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
по: Poupak Fallahi, и др.
Опубликовано: (2021-04-01)

Predictive Factors of Development of Graves’ Ophthalmopathy for Patients with Juvenile Graves’ Disease
по: Dalia Jarusaitiene, и др.
Опубликовано: (2016-01-01)

The Immune Tolerance Role of the HMGB1-RAGE Axis
по: Haruki Watanabe, и др.
Опубликовано: (2021-03-01)

HMGB1-RAGE signaling pathway in pPROM
по: Huan Yan, и др.
Опубликовано: (2018-04-01)

Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism
по: Rosario Le Moli, и др.
Опубликовано: (2020-06-01)

The Emerging Role of Small Extracellular Vesicles in Inflammatory Airway Diseases
по: Katarzyna Piszczatowska, и др.
Опубликовано: (2021-02-01)

Asssociation of vitamin D with autoimmune ophthalmopathy in Graves’ disease
по: Yu.V. Buldygina, и др.
Опубликовано: (2020-01-01)

On selenium deficiency in Graves’ disease patients with autoimmune ophthalmopathy
по: Yu.V. Buldygina, и др.
Опубликовано: (2019-04-01)

Current and promising therapies based on the pathogenesis of Graves’ ophthalmopathy
по: Xin Zhang, и др.
Опубликовано: (2023-11-01)

Evaluation of the Effect of Proptosis on Choroidal Thickness in Graves’ Ophthalmopathy
по: Gamze Yıldırım, и др.
Опубликовано: (2020-08-01)

Evaluation of Galectin-3 in Graves’ Disease With and Without Ophthalmopathy
по: Muhammed Akın, и др.
Опубликовано: (2023-04-01)

Evaluation of the patients with Grave’s ophthalmopathy after the corticosteroids treatment
по: Janićijević-Petrović Mirjana, и др.
Опубликовано: (2012-01-01)

Maukirana grahonmada – Psychiatric manifestations of Graves' hyperthyroidism and ophthalmopathy?
по: Prasad Mamidi, и др.
Опубликовано: (2018-01-01)

Update on the medical treatment of Graves&rsquo; ophthalmopathy
по: Gregory J Griepentrog, и др.
Опубликовано: (2009-12-01)

Proptosis is associated with thiol-disulfide in patients with Graves’ ophthalmopathy
по: Fettah Acibucu, и др.
Опубликовано: (2022-04-01)